Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

Arteriosclerosis, thrombosis, and vascular biology - 1 Feb 2011

Rossouw Jacques, Bray Paul, Liu Jingmin, Kooperberg Charles, Hsia Judith, Lewis Cora, Cushman Mary, Bonds Denise, Hendrix Susan, Papanicolaou George, Howard Timothy, Herrington David

Abstract excerpt

OBJECTIVE: To test whether estrogen receptor polymorphisms modify the effects of postmenopausal hormone therapy on biomarkers and on risk of coronary heart disease events, stroke, or venous thromboembolism. METHODS AND RESULTS: The design was a nested case-control study in the Women's Health Init...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Coronary Disease
Share to Estrogen Receptor alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Receptor beta

Share to Estrogen Replacement Therapy

Share to Receptors, Estrogen

Share to Stroke

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 21106950
DOI: 10.1161/ATVBAHA.110.215087
PMCID: PMC3074605

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21106950-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.PMID 21106950Read ↗

Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis.Semantic proximity Read ↗

Invited review: Pharmacogenetics of estrogen replacement therapy.Semantic proximity Read ↗

Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis.Semantic proximity Read ↗

DNA microarray-based analysis of single nucleotide polymorphisms may be useful for assessing the risks and benefits of hormone therapy.Semantic proximity Read ↗

Plasma estrogen levels, estrogen receptor gene variation, and ischemic arterial disease in postmenopausal women: the three-city prospective cohort study.Semantic proximity Read ↗

Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk.Semantic proximity Read ↗

Variation in the estrogen receptor alpha gene and risk of stroke: the Rotterdam Study.Semantic proximity Read ↗

Estrogen therapy and thrombotic risk.Semantic proximity Read ↗

Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.Semantic proximity Read ↗

Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms.Semantic proximity Read ↗

Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.Semantic proximity Read ↗

Oral contraceptives, hormone therapy and cardiovascular risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.